162 related articles for article (PubMed ID: 9157098)
1. A rapid method for evaluating the necessity for both a behavioral intervention and methylphenidate.
Kayser KH; Wacker DP; Derby KM; Andelman MS; Golonka Z; Stoner EA
J Appl Behav Anal; 1997; 30(1):177-80. PubMed ID: 9157098
[No Abstract] [Full Text] [Related]
2. A preliminary analysis of interactive effects between common classroom contingencies and methylphenidate.
Northup J; Jones K; Broussard C; DiGiovanni G; Herring M; Fusilier I; Hanchey A
J Appl Behav Anal; 1997; 30(1):121-5. PubMed ID: 9157096
[TBL] [Abstract][Full Text] [Related]
3. Transdermal methylphenidate, behavioral, and combined treatment for children with ADHD.
Pelham WE; Burrows-Maclean L; Gnagy EM; Fabiano GA; Coles EK; Tresco KE; Chacko A; Wymbs BT; Wienke AL; Walker KS; Hoffman MT
Exp Clin Psychopharmacol; 2005 May; 13(2):111-26. PubMed ID: 15943544
[TBL] [Abstract][Full Text] [Related]
4. Sequential evaluation of behavioral treatments and methylphenidate dosage for children with attention deficit hyperactivity disorder.
Gulley V; Northup J; Hupp S; Spera S; LeVelle J; Ridgway A
J Appl Behav Anal; 2003; 36(3):375-8. PubMed ID: 14596580
[TBL] [Abstract][Full Text] [Related]
5. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Dec; (8):280-90. PubMed ID: 12603883
[No Abstract] [Full Text] [Related]
6. Effect of long-acting OROS methylphenidate on routine driving in young adults with attention-deficit/hyperactivity disorder.
Cox DJ; Mikami AY; Cox BS; Coleman MT; Mahmood A; Sood A; Moore M; Burket R; Merkel RL
Arch Pediatr Adolesc Med; 2008 Aug; 162(8):793-4. PubMed ID: 18678816
[No Abstract] [Full Text] [Related]
7. Attention deficit hyperactivity disorder in children.
Ramchandani P; Joughin C; Zwi M
Clin Evid; 2002 Jun; (7):262-71. PubMed ID: 12230649
[No Abstract] [Full Text] [Related]
8. Efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Lee SI; Hong SD; Kim SY; Kim EJ; Kim JH; Kim JH; Park MK; Park S; Park JH; Oh EY; Lim TS; Cheong S; Cho IH; Choi JW
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jan; 31(1):210-6. PubMed ID: 17046131
[TBL] [Abstract][Full Text] [Related]
9. Excessive masturbation and hypersexual behavior associated with methylphenidate.
Bilgiç A; Gürkan K; Türkoğlu S
J Am Acad Child Adolesc Psychiatry; 2007 Jul; 46(7):789-90. PubMed ID: 17581441
[No Abstract] [Full Text] [Related]
10. Do typical clinical doses of methylphenidate cause tics in children treated for attention-deficit hyperactivity disorder?
Killeen MR
J Child Fam Nurs; 2000; 3(1):46-8. PubMed ID: 11022478
[No Abstract] [Full Text] [Related]
11. Letter to the editor: Comment on 'Acute impact of immediate release methylphenidate administered three times a day on sleep in children with attention-deficit/hyperactivity disorder'.
Olders H
J Pediatr Psychol; 2009; 34(1):108-9; author reply 110-2. PubMed ID: 19136567
[No Abstract] [Full Text] [Related]
12. Multisite controlled study of OROS methylphenidate in the treatment of adolescents with attention-deficit/hyperactivity disorder.
Wilens TE; McBurnett K; Bukstein O; McGough J; Greenhill L; Lerner M; Stein MA; Conners CK; Duby J; Newcorn J; Bailey CE; Kratochvil CJ; Coury D; Casat C; Denisco MJ; Halstead P; Bloom L; Zimmerman BA; Gu J; Cooper KM; Lynch JM
Arch Pediatr Adolesc Med; 2006 Jan; 160(1):82-90. PubMed ID: 16389216
[TBL] [Abstract][Full Text] [Related]
13. Impact of comorbid autism spectrum disorders on stimulant response in children with attention deficit hyperactivity disorder: a retrospective and prospective effectiveness study.
Santosh PJ; Baird G; Pityaratstian N; Tavare E; Gringras P
Child Care Health Dev; 2006 Sep; 32(5):575-83. PubMed ID: 16919137
[TBL] [Abstract][Full Text] [Related]
14. Better efficacy for the osmotic release oral system methylphenidate among poor adherents to immediate-release methylphenidate in the three ADHD subtypes.
Chou WJ; Chou MC; Tzang RF; Hsu YC; Gau SS; Chen SJ; Wu YY; Huang YF; Liang HY; Cheng H
Psychiatry Clin Neurosci; 2009 Apr; 63(2):167-75. PubMed ID: 19335386
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate in children with oppositional defiant disorder and both comorbid chronic multiple tic disorder and ADHD.
Gadow KD; Nolan EE; Sverd J; Sprafkin J; Schneider J
J Child Neurol; 2008 Sep; 23(9):981-90. PubMed ID: 18474932
[TBL] [Abstract][Full Text] [Related]
16. A randomized, double-blind, placebo-controlled, laboratory classroom assessment of methylphenidate transdermal system in children with ADHD.
McGough JJ; Wigal SB; Abikoff H; Turnbow JM; Posner K; Moon E
J Atten Disord; 2006 Feb; 9(3):476-85. PubMed ID: 16481664
[TBL] [Abstract][Full Text] [Related]
17. Focalin XR for ADHD.
Med Lett Drugs Ther; 2009 Mar; 51(1308):22-4. PubMed ID: 19305368
[No Abstract] [Full Text] [Related]
18. Efficacy of theophylline compared to methylphenidate for the treatment of attention-deficit hyperactivity disorder in children and adolescents: a pilot double-blind randomized trial.
Mohammadi MR; Kashani L; Akhondzadeh S; Izadian ES; Ohadinia S
J Clin Pharm Ther; 2004 Apr; 29(2):139-44. PubMed ID: 15068402
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.
Adler LA; Zimmerman B; Starr HL; Silber S; Palumbo J; Orman C; Spencer T
J Clin Psychopharmacol; 2009 Jun; 29(3):239-47. PubMed ID: 19440077
[TBL] [Abstract][Full Text] [Related]
20. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
[Next] [New Search]
